(TSPA) T. Rowe Price US Equity - Ratings and Ratios
U.S. Equity, Securities, Index, Neutral, Non-Diversified
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.4% |
| Value at Risk 5%th | 31.2% |
| Relative Tail Risk | 3.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | -0.46 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.451 |
| Beta | 0.945 |
| Beta Downside | 0.952 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.04% |
| Mean DD | 2.20% |
| Median DD | 1.01% |
Description: TSPA T. Rowe Price US Equity November 11, 2025
The T. Rowe Price US Equity Research ETF (NYSE ARCA:TSPA) targets at least 80% of its net assets-plus any investment-purpose borrowings-in U.S. equities, aiming to construct a portfolio that mirrors the risk-return profile of the S&P 500 while seeking alpha. The fund stays almost fully invested (≤ 5% cash), strives for sector neutrality relative to the index, and is classified as a non-diversified large-blend ETF.
Key metrics (as of the latest filing) include an expense ratio of 0.35% and assets under management of roughly $1.2 billion, with an annual turnover near 30%, indicating moderate trading activity. Recent performance has lagged the S&P 500 by about 0.8% y-td, reflecting the fund’s emphasis on research-driven stock selection rather than pure index tracking. Macro-level drivers such as U.S. corporate earnings growth, Federal Reserve policy on interest rates, and sector-specific trends-particularly in information technology and consumer discretionary, which together account for ~45% of the index weighting-are likely to influence TSPA’s excess return potential.
For a deeper, data-rich assessment of how TSPA’s research-centric approach stacks up against peers, you might explore ValueRay’s analytical tools to uncover hidden risk-adjusted performance signals.
TSPA ETF Overview
| Market Cap in USD | 2,034m |
| Category | Large Blend |
| TER | 0.34% |
| IPO / Inception | 2021-06-08 |
| Return 12m vs S&P 500 | -0.89% |
| Analyst Rating | - |
TSPA Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 0.45% |
| Yield on Cost 5y | 0.76% |
| Yield CAGR 5y | 14.89% |
| Payout Consistency | 88.7% |
| Payout Ratio | - |
TSPA Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 20.51% |
| CAGR/Max DD Calmar Ratio | 1.08 |
| CAGR/Mean DD Pain Ratio | 9.32 |
| Current Volume | 159.1k |
| Average Volume | 159.1k |
What is the price of TSPA shares?
Over the past week, the price has changed by -3.12%, over one month by -2.96%, over three months by +2.18% and over the past year by +10.85%.
Is TSPA a buy, sell or hold?
What are the forecasts/targets for the TSPA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 46.8 | 14.1% |
TSPA Fundamental Data Overview November 21, 2025
Beta = 0.99
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.03b USD (2.03b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.03b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.03b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.50% (E(2.03b)/V(2.03b) * Re(9.50%) + (debt-free company))
Discount Rate = 9.50% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for TSPA ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle